New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer

INTRODUCTION: Lack of diagnostic makers results in loss of operation opportunity in that most patients are diagnosed at the late stage. Pancreatic cancer (PC) has been regarded as a fatal disease with a 5-year survival rate below 10%. Therefore, the development of diagnostic biomarkers for PC is in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Wei, Tang, Wanyan, Xie, Yibin, Wang, Shaoming, Chen, Yingtai, Qi, Jun, Qiao, Youlin, Ma, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346769/
https://www.ncbi.nlm.nih.gov/pubmed/27713117
http://dx.doi.org/10.18632/oncotarget.12406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346769/
https://www.ncbi.nlm.nih.gov/pubmed/27713117
http://dx.doi.org/10.18632/oncotarget.12406

Ejemplares similares